EZH2 inhibition in ARID1A mutated clear cell and endometrioid ovarian and endometrioid endometrial cancers

Clear cell carcinoma and endometrioid adenocarcinoma are histologic subtypes of ovarian and uterine cancer that demonstrate unique clinical behavior but share common underlying genomic aberrations and oncogenic pathways. ARID1A mutations are more frequently identified in these tumors, in comparison...

Descripción completa

Detalles Bibliográficos
Autores principales: Alldredge, Jill K., Eskander, Ramez N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663065/
https://www.ncbi.nlm.nih.gov/pubmed/29093822
http://dx.doi.org/10.1186/s40661-017-0052-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663065/
https://www.ncbi.nlm.nih.gov/pubmed/29093822
http://dx.doi.org/10.1186/s40661-017-0052-y

Ejemplares similares